Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/12942
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Halimi Vesa | en_US |
dc.contributor.author | Daci Armond | en_US |
dc.contributor.author | Simona Stojanovska | en_US |
dc.contributor.author | Panovska-Stavridis Irina | en_US |
dc.contributor.author | Milena Stevanovic | en_US |
dc.contributor.author | Filipce Venko | en_US |
dc.contributor.author | Grozdanova, Aleksandra | en_US |
dc.date.accessioned | 2021-05-31T12:21:23Z | - |
dc.date.available | 2021-05-31T12:21:23Z | - |
dc.date.issued | 2020-05-16 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.12188/12942 | - |
dc.language.iso | en | en_US |
dc.publisher | Journal of Pharmaceutical Policy and Practice | en_US |
dc.title | Current regulatory approaches for accessing potential COVID-19 therapies | en_US |
dc.type | Article | en_US |
dc.identifier.doi | https://doi.org/10.1186/s40545-020-00222-6 | - |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
crisitem.author.dept | Faculty of Pharmacy | - |
Appears in Collections: | Faculty of Pharmacy: Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s40545-020-00222-6.pdf | 488.99 kB | Adobe PDF | View/Open |
Page view(s)
58
checked on Apr 26, 2024
Download(s)
11
checked on Apr 26, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.